|
Volumn 41, Issue 4, 2001, Pages 351-356
|
Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan
|
Author keywords
Congenital malformations; Migraine; Pregnancy; Registry; Sumatriptan
|
Indexed keywords
CAFFEINE;
CHLORCYCLIZINE;
DIHYDROERGOTAMINE;
ERGOTAMINE;
PIZOTIFEN;
SUMATRIPTAN;
ARTICLE;
DISEASE CLASSIFICATION;
HUMAN;
LOW BIRTH WEIGHT;
MAJOR CLINICAL STUDY;
MIGRAINE;
PREGNANCY COMPLICATION;
PREMATURITY;
PRIORITY JOURNAL;
RISK FACTOR;
SMOKING HABIT;
STATISTICAL ANALYSIS;
SWEDEN;
TERATOGENESIS;
TREATMENT OUTCOME;
ABNORMALITIES;
ADULT;
DELIVERY, OBSTETRIC;
FEMALE;
HUMANS;
INFANT, NEWBORN;
MIDDLE AGED;
MIGRAINE DISORDERS;
PARITY;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PREGNANCY OUTCOME;
PROSPECTIVE STUDIES;
RISK FACTORS;
SEROTONIN AGONISTS;
SUMATRIPTAN;
SWEDEN;
|
EID: 0035035426
PISSN: 00178748
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-4610.2001.111006351.x Document Type: Article |
Times cited : (99)
|
References (6)
|